DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%.
The growth of this market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
This report segments the market into product, application, end user, and region. Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. In 2017, synthesized oligonucleotides are estimated to account for the largest share of the total market, followed by reagents. The growth of the synthesized oligonucleotides segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics.
Market Dynamics
Drivers
- Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
- Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
- Rise in Venture Capital Investments
Restraints
- Price Erosion of Synthesized Oligonucleotides
- Lack of a Unified Set of Regulations for Therapeutic Oligonucleotides
Opportunities
- Emerging Asian Markets
Challenges
- Large-Scale Synthesis of Oligonucleotides
- Delivery of Oligonucleotide Drugs to Specific Targets
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Oligonucleotide Synthesis Market, by Product
7 Oligonucleotide Synthesis Market, by Application
8 Oligonucleotide Synthesis Market, by End User
9 Oligonucleotide Synthesis Market, by Region
10 Competitive Landscape
11 Company Profiles
- Agilent Technologies
- ATDBio
- Bio-Synthesis
- Bioautomation
- Eurofins Genomics
- Eurogentec
- GE Healthcare
- Genedesign (Part of Ajinomoto)
- Genscript
- Integrated DNA Technologies
- LGC Biosearch Technologies
- Merck KGaA
- Nitto Denko Avecia
- Thermo Fisher Scientific
- TriLink Biotechnologies (Part of Maravai Lifesciences)
For more information about this report visit https://www.researchandmarkets.com/research/zhhbfv/global?w=4
